Antinociceptive effect of intra-hippocampal CA1 and dentate gyrus injection of MK801 and AP5 in the formalin test in adult male rats

European Journal of Pharmacology

Volumn 562, Issue 1-2, 2007, Pages 39-46

  Soleimannejad, Elaheh ^a   Naghdi, Nasser ^b   Semnanian, Saeed ^a,c   Fathollahi, Yaghoub ^c   Kazemnejad, Anoshirvan ^c  

^a INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

(Rat); Formalin test; Hippocampus; NMDA receptor; Nociception

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; DIZOCILPINE; FORMALDEHYDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DRUG DOSE COMPARISON; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

2-AMINO-5-PHOSPHONOVALERATE; ANALGESICS; ANIMALS; DENTATE GYRUS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FORMALDEHYDE; HIPPOCAMPUS; MALE; MICROINJECTIONS; MODELS, ANATOMIC; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 33947596039     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.051     Document Type: Article

References (60)

1. Abbott F.V., Franklin K.B., and Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60 (1995) 91-102
2. Aloisi A.M., Zimmermann M., and Herdegen T. Sex-dependent effects of formalin and restraint on c-Fos expression in the septum and hippocampus of the rat. Neuroscience 81 (1997) 951-958
3. Amaral D.G., and Witter M.P. Hippocampal formation. In: Paxinos G. (Ed). The Rat Nervous System vol. 351 (1995), Academic Press, Sydney 443-492
4. Baude A., Nusser Z., Molnar E., McIlhinney R.A., and Somogyi P. High-resolution immunogold localization of AMPA type glutamate receptor subunits at synaptic and non-synaptic sites in rat hippocampus. Neuroscience 69 (1995) 1031-1055
5. Coderre T.J., and Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J. Neurosci. 12 (1992) 3665-3670
6. Coderre T.J., and Melzack R. The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. J. Neurosci. 12 (1992) 3671-3675
7. Coderre T., and van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. Pain 59 (1994) 345-352
8. Coderre T., and van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites. Pain 59 (1994) 353-359
9. Coderre T.J., Vaccarino A.L., and Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res. 535 (1990) 155-158
10. Cohen S.R., Abbott F.V., and Melzack R. Unilateral analgesia produced by intraventricular morphine. Brain Res. 303 (1984) 277-287
11. D'Amico M., Berrino L., Maione S., Filippelli A., De Novellis V., and Rossi F. Endotelin-1 in periaquaductal gray area of mice induces analgesia via glutamatergic receptors. Pain 65 (1996) 205-209
12. Delgado J.M.R. Cerebral structures involved in transmission and elaboration of noxious stimulation. J. Neurophysiol. 18 (1955) 261-275
13. Dickenson A., Chapman V., and Green G. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen. Pharmacol. 28 (1997) 633-638
14. Eaton S.A., and Salt T.E. N-Methyl-d-aspartate antagonists reduce the responses of rat thalamic neurones to noxious stimulation. J. Physiol. (London) 394 (1987)
15. Eaton S.A., and Salt T.E. Thalamic NMDA receptors and nociceptive sensory synaptic transmission. Neurosci. Lett. 110 (1990) 297-302
16. Eisenberg E., Vos B.P., and Strassmanm A.M. The NMDA antagonist Memantine blocks pain behavior in a rat model of formalin-induced facial pain. Pain 54 (1993) 301-307
17. Enarson M.C., Hays H., and Wodroffe M.A. Clinical experience with oral ketamine. J. Pain Symptom Manage. 17 (1999) 384-386
18. Funahashi M., He Y.-F., Sugimoto T., and Matsuo R. Noxious tooth pulp stimulation suppresses c-fos expression in the rat hippocampal formation. Brain Res. 827 (1999) 215-220
19. Gloor P., Olivier A., and Quesney L.F. The role of the amygdala in the expression of psychic phenomena in temporal lobe seizures. In: Ben-Ari Y. (Ed). The Amygdaloid Complex: INSERM Symposium vol. 20 (1981), Elsevier, New York 489-498
20. Gol A., and Faibish G.M. Effects of human hippocampal ablation. J. Neurosurg. 26 (1967) 390-398
21. Halgren E., Walter R.D., Cherlow D.G., and Crandall P.H. Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain 101 (1978) 83-117
22. Hardman J.G., Limbird L.E., Molinoff P.B., and Gilman R.W. Goodman & Gilman's The pharmacological basis of therapeutics. Ninth (International) edition (1996), McGraw-Hill, New York 281 Chapter 21
23. Henderson D.J., Withington B.S., Wilson J.A., and Morrison L.M. Perioperative dextromethorphan reduces postoperative pain after hysterectomy. Anesth. Analg. 89 (1999) 399-402
24. Henke P.G. The telencephalic limbic system and experimental gastric pathology: a review. Neurosci. Biobehav. Rev. 6 (1982) 381-390
25. Hudespith M.J. Glutamate: a role in normal brain function, anaesthesia, analgesia, and CNS injury. Br. J. Anaesth. 78 (1997) 731-747
26. Kalb R.G., and Fox A.J. Synchronized overproduction of AMPA, kainite, and NMDA glutamate receptors during human spinal cord development. J. Comp. Neurol. 384 (1997) 200-210
27. Khanna S. Dorsal hippocampus field CA1 pyramidal cell responses to a persistent versus an acute nociceptive stimulus and their septal modulation. Neuroscience 77 (1997) 713-721
28. Khanna S., and Sinclaire J.G. Responses in the CA1 region of the rat hippocampus to a noxious stimulus. Exp. Neurol. 117 (1992) 28-35
29. Khanna S., and Zheng F. Hippocampal field CA1 interneuronal nociceptive responses: modulation by medial septal region and morphine. Neuroscience 93 (1999) 45-55
30. Khanna S., Chang L.S., Jiang F., and Koh H.C. Nociception-driven decreased induction of Fos protein in ventral hippocampus field CA1 of the rat. Brain Res. 1004 (2004) 167-176
31. Klepstad P., Maurset A., Moberg E.R., and Oye I. Evidence of a role for NMDA receptors in pain perception. Eur. J. Pharmacol. 187 (1990) 513-518
32. Kristensen J.D., Svensson B., and Gordh T. The NMDA receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 51 (1992) 249-253
33. Maione S., Marabese I., Oliva P., de Novellis V., Stella L., Rossi F., Fillippelli A., and Rossi F. Periaqueductal gray matter metabotropic glutamate and GABA decrease following subcutaneous formalin induction in rat. NeuroReport 10 (1999) 1043-1045
34. Maione S., Oliva P., Marabese I., Palazzo E., Rossi F., Berrino L., Rossi F., and Fillippelli A. Periaqueductal gray matter metabotropic glutamate receptors modulate formalin-induced nociception. Pain 85 (2000) 183-189
35. McKenna J.E., and Melzack R. Analgesia produced by lidocaine microinjection into the dentate gyrus. Pain 49 (1992) 105-112
36. McKenna J.E., and Melzack R. Injection of AP5 into rat centromedial thalamus causes analgesia in the formalin test. Canadian Pain Society, Annual Meeting Programme (1994) 30
37. McKenna J.E., and Melzack R. Blocking NMDA receptors in the hippocampal dentate gyrus with AP5 produces analgesia in the formalin pain test. Exp. Neurol. 172 (2001) 92-99
38. Melzack R., and Casey K. Sensory, motivational and central control determinants of pain. In: Kenshalo D. (Ed). The Skin Senses (1968), Thomas, Springfield 423-439
39. Mugnaini M., Van Amsterdam F.T., Ratti E., Trist D.G., and Bowery N.G. Regionally different N-methyl-d-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain. Br. J. Pharmacol. 119 (1996) 819-828
40. Nadel L. Dorsal and ventral hippocampal lesions and behavior. Physiol. Behav. 3 (1968) 891-900
41. Nusser Z., Lujan R., Laube G., Roberts J.D., Molnar E., and Somogyi P. Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus. Neuron 21 (1998) 545-559
42. Olton D.S., and Issacson R.L. Hippocampal lesions and active avoidance. Physiol. Behav. 3 (1968) 719-724
43. Pearse D., Mirza A., and Leah J. Jun, Fos and Krox in the hippocampus after noxious stimulation: simultaneous-input-dependent expression and nuclear speckling. Brain Res. 894 (2001) 193-208
44. Pud D., Eisenberg E., Spitzer A., Adler R., Fried G., and Yarnitsky D. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain 75 (1998) 349-354
45. Rabben T., Skjelbred P., and Oye I. Prolonged analgesic effect of ketamine, an N-methyl-d-aspartate receptor inhibitor, in patients with chronic pain. J. Pharmacol. Exp. Ther. 289 (1999) 1060-1066
46. Racca C., Stephenson F.A., Streit P., Roberts J.D., and Somogyi P. NMDA receptor content of synapses in stratum radiatum of the hippocampal CA1 area. J. Neurosci. 20 (2000) 2512-2522
47. 3H]dextrophan binding sites in rat brain determined by quantitative autoradiography. J. Pharmacol. Exp. Ther. 277 (1996) 1823-1836
48. Salt T.E., Wilson D.G., and Prasad S.K. Antagonism of N-methylaspartate and synaptic responses of neurones in the rat ventrobasal thalamus by ketamine and MK-801. Br. J. Pharmacol. 94 (1988) 443-448
49. Schmid R.L., Sandler A.N., and Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain 82 (1999) 111-125
50. Schurr A., Paybe R.S., and Rigor B.M. Synergism between ditiazem and MK801 but not APV in protecting hippocampal slices against hypoxic damage. Brain Res. 684 (1995) 233-236
51. Seltzer Z., Cohn S., Ginzberg R., and Beilin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain 45 (1991) 69-75
52. Sinclair J.G., and Lo G.F. Morphine, but not atrophine, blocks nociceptor-driven activity in rat dorsal hippocampal neurons. Neurosci. Lett. 68 (1986) 47-50
53. Soleimannejad E., Semnanian S., Fathollahi Y., and Naghdi N. Microinjection of ritanserin into the dorsal hippocampal CA1 and dentate gyrus suppresses nociceptive behavior in adult male rat. Behav. Brain Res. 168 (2006) 221-225
54. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., and Hole K. The formalin test: an evaluation of the method. Pain 51 (1992) 5-17
55. Tucci S., Rada P., and Hernandez L. Role of glutamate in the amygdale and lateral hypothalamus in conditioned taste aversion. Brain Res. 813 (1998) 44-49
56. Vaccarino A.L., and Melzack R. Temporal processes of formalin pain: differential role of the cingulum bundle, fornix pathway and medial bulboreticular formation. Pain 49 (1992) 257-271
57. Vizi E.S., and Kiss J.P. Neurochemistry and pharmacology of the major 477 hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus 8 (1998) 566-607
58. Walters E.T. Site-specific sensitization of defensive reflexes in Aplysia: a simple model of long-term hyperalgesia. J. Neurosci. 7 (1987) 400-407
59. Wei F., Xu Z.C., Qu Z., Milbrandt J., and Zhuo M. Role of Egr1 in hippocampal synaptic enhancement induced by tetanic stimulation and amputation. J. Cell Biol. 149 (2000) 1325-1333
60. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 2 (1983) 109-110